Eva Xepapadaki

466 total citations
19 papers, 339 citations indexed

About

Eva Xepapadaki is a scholar working on Endocrinology, Diabetes and Metabolism, Epidemiology and Surgery. According to data from OpenAlex, Eva Xepapadaki has authored 19 papers receiving a total of 339 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Endocrinology, Diabetes and Metabolism, 9 papers in Epidemiology and 8 papers in Surgery. Recurrent topics in Eva Xepapadaki's work include Diabetes, Cardiovascular Risks, and Lipoproteins (10 papers), Adipose Tissue and Metabolism (7 papers) and Lipid metabolism and disorders (5 papers). Eva Xepapadaki is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (10 papers), Adipose Tissue and Metabolism (7 papers) and Lipid metabolism and disorders (5 papers). Eva Xepapadaki collaborates with scholars based in Greece, Cyprus and Israel. Eva Xepapadaki's co-authors include Kyriakos E. Kypreos, Evangelia Zvintzou, Eleni A. Karavia, Caterina Constantinou, Christina Kalogeropoulou, Περιστέρα-Ιωάννα Πετροπούλου, George Panayiotakopoulos, Frank J. Gonzalez, Shlomo Sasson and Maria Konstandi and has published in prestigious journals such as Biochemistry, Diabetologia and American Journal of Physiology-Endocrinology and Metabolism.

In The Last Decade

Eva Xepapadaki

19 papers receiving 334 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eva Xepapadaki Greece 12 131 107 81 74 74 19 339
Shiyin Long China 12 132 1.0× 143 1.3× 97 1.2× 69 0.9× 39 0.5× 25 374
Rebecca Hutcheson United States 10 92 0.7× 52 0.5× 104 1.3× 51 0.7× 65 0.9× 13 379
L. Perségol France 10 240 1.8× 190 1.8× 113 1.4× 54 0.7× 40 0.5× 14 409
Mohsen Firoozrai Iran 14 118 0.9× 69 0.6× 65 0.8× 40 0.5× 95 1.3× 42 424
Guiyun Ruan China 6 94 0.7× 96 0.9× 83 1.0× 71 1.0× 31 0.4× 6 295
Anja Hofmann Germany 13 49 0.4× 120 1.1× 145 1.8× 53 0.7× 96 1.3× 37 514
Adriana Machado‐Lima Brazil 15 155 1.2× 136 1.3× 111 1.4× 71 1.0× 100 1.4× 34 453
Andreas Sourlas Greece 12 172 1.3× 240 2.2× 102 1.3× 69 0.9× 49 0.7× 18 517
Narges Mohammadtaghvaei Iran 11 89 0.7× 40 0.4× 120 1.5× 89 1.2× 56 0.8× 33 356
Tarek A. Abd El-Aziz Egypt 13 87 0.7× 109 1.0× 79 1.0× 65 0.9× 39 0.5× 28 459

Countries citing papers authored by Eva Xepapadaki

Since Specialization
Citations

This map shows the geographic impact of Eva Xepapadaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Xepapadaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Xepapadaki more than expected).

Fields of papers citing papers by Eva Xepapadaki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Xepapadaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Xepapadaki. The network helps show where Eva Xepapadaki may publish in the future.

Co-authorship network of co-authors of Eva Xepapadaki

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Xepapadaki. A scholar is included among the top collaborators of Eva Xepapadaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Xepapadaki. Eva Xepapadaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Zvintzou, Evangelia, et al.. (2023). High-Density Lipoprotein in Metabolic Disorders and Beyond: An Exciting New World Full of Challenges and Opportunities. Pharmaceuticals. 16(6). 855–855. 10 indexed citations
2.
Karavia, Eleni A., Eva Xepapadaki, Evangelia Zvintzou, et al.. (2022). Benefits of a fixed-dose combination of standardized P. mume extract with choline on adipose tissue mitochondrial metabolic activity and pancreatic β-islet secretory capacity in mice. Phytomedicine Plus. 2(3). 100317–100317. 1 indexed citations
3.
Xepapadaki, Eva, et al.. (2021). HDL and type 2 diabetes: the chicken or the egg?. Diabetologia. 64(9). 1917–1926. 48 indexed citations
4.
Zvintzou, Evangelia, et al.. (2021). High density lipoprotein in atherosclerosis and coronary heart disease: Where do we stand today?. Vascular Pharmacology. 141. 106928–106928. 19 indexed citations
5.
Zvintzou, Evangelia, et al.. (2021). Functional interaction between apolipoproteins A2 and E in the triglyceride rich lipoprotein metabolism: Is LDLR involved?. Atherosclerosis. 331. e123–e123. 1 indexed citations
6.
Xepapadaki, Eva, et al.. (2020). Tissue-specific functional interaction between apolipoproteins A1 and E in cold-induced adipose organ mitochondrial energy metabolism. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1866(3). 158859–158859. 4 indexed citations
7.
Zvintzou, Evangelia, et al.. (2019). Pleiotropic effects of apolipoprotein A-Ⅱ on high-density lipoprotein functionality, adipose tissue metabolic activity and plasma glucose homeostasis. Journal of Biomedical Research. 34(1). 14–14. 15 indexed citations
8.
Xepapadaki, Eva, Giuseppe Maulucci, Caterina Constantinou, et al.. (2019). Impact of apolipoprotein A1- or lecithin:cholesterol acyltransferase-deficiency on white adipose tissue metabolic activity and glucose homeostasis in mice. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1865(6). 1351–1360. 21 indexed citations
9.
Xepapadaki, Eva, et al.. (2019). Τhe Antioxidant Function of HDL in Atherosclerosis. Angiology. 71(2). 112–121. 39 indexed citations
10.
Konstandi, Maria, Kyriakos E. Kypreos, Tsutomu Matsubara, et al.. (2019). Adrenoceptor‐related decrease in serum triglycerides is independent of PPARα activation. FEBS Journal. 286(21). 4328–4341. 5 indexed citations
11.
Kalogeropoulou, Christina, Eva Xepapadaki, Eleni A. Karavia, et al.. (2019). Isoform and tissue dependent impact of apolipoprotein E on adipose tissue metabolic activation: The role of apolipoprotein A1. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1865(2). 158551–158551. 6 indexed citations
12.
Constantinou, Caterina, et al.. (2018). Apolipoprotein E in diet-induced obesity: a paradigm shift from conventional perception. Journal of Biomedical Research. 32(3). 183–183. 12 indexed citations
13.
Kypreos, Kyriakos E., Rafael Bitzur, Eleni A. Karavia, et al.. (2018). Pharmacological Management of Dyslipidemia in Atherosclerosis: Limitations, Challenges, and New Therapeutic Opportunities. Angiology. 70(3). 197–209. 16 indexed citations
14.
Andreadou, Ioanna, Frank J. Gonzalez, Antigone Lazou, et al.. (2018). The olive constituent oleuropein, as a PPARα agonist, markedly reduces serum triglycerides. The Journal of Nutritional Biochemistry. 59. 17–28. 35 indexed citations
15.
Kalogeropoulou, Christina, et al.. (2017). Site-specific effects of apolipoprotein E expression on diet-induced obesity and white adipose tissue metabolic activation. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1864(2). 471–480. 11 indexed citations
16.
Karavia, Eleni A., Christina Kalogeropoulou, Nikolaos Papachristou, et al.. (2015). Deficiency in apolipoprotein A-I ablates the pharmacological effects of metformin on plasma glucose homeostasis and hepatic lipid deposition. European Journal of Pharmacology. 766. 76–85. 14 indexed citations
17.
Constantinou, Caterina, Eleni A. Karavia, Eva Xepapadaki, et al.. (2015). Advances in high-density lipoprotein physiology: surprises, overturns, and promises. American Journal of Physiology-Endocrinology and Metabolism. 310(1). E1–E14. 34 indexed citations
18.
Karavia, Eleni A., Nikolaos Papachristou, George Sakellaropoulos, et al.. (2015). Scavenger Receptor Class B Type I Regulates Plasma Apolipoprotein E Levels and Dietary Lipid Deposition to the Liver. Biochemistry. 54(36). 5605–5616. 21 indexed citations
19.
Karavia, Eleni A., Evangelia Zvintzou, Περιστέρα-Ιωάννα Πετροπούλου, et al.. (2014). HDL quality and functionality: what can proteins and genes predict?. Expert Review of Cardiovascular Therapy. 12(4). 521–532. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shiyin Long Breakdown of academic impact, for papers by Rebecca Hutcheson Breakdown of academic impact, for papers by L. Perségol Breakdown of academic impact, for papers by Mohsen Firoozrai Breakdown of academic impact, for papers by Guiyun Ruan Breakdown of academic impact, for papers by Anja Hofmann Breakdown of academic impact, for papers by Adriana Machado‐Lima Breakdown of academic impact, for papers by Andreas Sourlas Breakdown of academic impact, for papers by Narges Mohammadtaghvaei Breakdown of academic impact, for papers by Tarek A. Abd El-Aziz
Rankless by CCL
2026